Patents-Review.com
ClassID:

170493 ⎘

G01N2333/7056 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM

Sub-classes:
Recent Application in this class:
#1
20260028407
2026-01-29

MODIFIED ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

 #2
20250340652
2025-11-06

HUMAN ANTI-HUMAN PLA2R ANTIBODY STANDARD SUBSTANCE AND USE THEREOF

 #3
20250332196
2025-10-30

ANTI-CLL-1 CHIMERIC ANTIGEN RECEPTORS, ENGINEERED CELLS AND RELATED METHODS

 #4
20250321228
2025-10-16

MICROIMPRINTING OF ANTIBODIES AND BIOMOLECULES FOR CELL PHENOTYPING AND ACTIVATION

 #5
20240288435
2024-08-29

METHOD FOR PREDICTING RISK FOR THROMBOSIS IN CANCER PATIENT USING SOLUBLE CLEC2

 #6
20220206012
2022-06-30

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

 #7
20220196523
2022-06-23

IMMUNOCHROMATOGRAPHY

 #8
20210322513
2021-10-21

METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER

 #9
20190248903
2019-08-15

Anti-CLL-1 antibodies and immunoconjugates

 #10
20180250360
2018-09-06

METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER

 #11
20180044421
2018-02-15

Anti-CLL-1 antibodies and immunoconjugates

 #12
20180044420
2018-02-15

Anti-CLL-1 antibodies and immunoconjugates

 #13
20180009894
2018-01-11

Anti-CLL-1 antibodies and immunoconjugates

 #14
20170153250
2017-06-01

Diagnosis and treatment of Kawasaki disease

 #15
20160291035
2016-10-06

Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels

 #16
20160237118
2016-08-18

Leukemia stem cell targeting ligands and methods of use

 #17
20160200817
2016-07-14

Methods Of Identifying Anti-Inflammatory Compounds

 #18
20160075787
2016-03-17

Anti-CLL-1 antibodies and immunoconjugates

 #19
20140248633
2014-09-04

Leukemia stem cell targeting ligands and methods of use

 #20
20120251557
2012-10-04

GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF

 #21
20120058493
2012-03-08

BIOMARKER FOR MONITORING PATIENTS

 #22
20110177084
2011-07-21

Use application of sugar chain-recognizing receptor

 #23
20110076277
2011-03-31

Methods of identifying anti-inflammatory compounds

 #24
20100330066
2010-12-30

Methods for use with BAFF antagonists

 #25
20100311053
2010-12-09

USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK

 #26
20100159484
2010-06-24

Chemotaxis diagnostic

 #27
20100028418
2010-02-04

GAINAC SPECIFIC BINDING MOLECULES AND USES THEREOF

 #28
20090263378
2009-10-22

Methods of identifying anti-inflammatory compounds

 #29
20090118481
2009-05-07

High Affinity Nucleic Acid Ligands To Lectins

 #30
20080274475
2008-11-06

HLA-E BINDING

 #31
20080039402
2008-02-14

Peptides and peptidomimetics binding to CD23

 #32
20070218497
2007-09-20

Quick Test for the Diagnosis of Alzheimer's Disease

 #33
20060275214
2006-12-07

Methods of screening for anti-inflammatory drugs and use thereof

 #34
20060142187
2006-06-29

Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activity

 #35
20060121023
2006-06-08

Method to decrease nonspecific staining by Cy5

 #36
20050221291
2005-10-06

Dc-sign isoforms, related compositions and methods for their use in disease therapy